Original Research

Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies

Singh RP, Staurenghi G, Pollack A, Adewale A, Walker TM, Sager D, Lehmann R

Clinical Ophthalmology 2017, 11:1021-1029

Published Date: 29 May 2017